Our preliminary data suggest that GLP-1s suppress intake through a different mechanism. GLP-1 drugs slow gastric emptying, which appears to delay the rise of alcohol levels in the blood
Many Pakistani doctors prescribe Ozempic off-label for: Clinical Evidence The SUSTAIN-1 trial showed: Up to 57 kg weight loss over 30 weeks Better appetite control Improved metabolic markers However: Wegovy (higher-dose semaglutide) is the FDA-approved weight-loss version, not Ozempic
Notably, 98.3% of patients treated with adagrasib had already received immunotherapy and chemotherapy, so it is a new hope for these patient groups
The small volumes mean less liquid to inject, which can reduce injection site reactions
Monitor Electrolytes : Regularly check and balance electrolyte levels, especially potassium and magnesium
But it can also come with an unwelcome side effect: diarrhea